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Background and Objective

Results: Discrepant Regions and Variant Interpretation

Background
•

•

Clinical exome and genome sequencing (CEGS) at our institution
utilizes assembly GRCh37 of the Human Reference Genome for
variant calling and annotation. However, GRCh37 contains known
disease-associated variants such as Factor V Leiden (FVL):
c.1601G>A (p.Arg534Gln). Individuals homozygous for this
nonsynonymous change would not be detected by CEGS pipelines
using GRCh37 as such individuals would not be variant from the
reference genome. Although the existence of these diseaseassociated variants in GRCh37 is known in general, little work has
been done to catalog their locations or determine their impact on
clinical variant detection and interpretation.

Call in gnomAD/CEGS DB: RECQL4:c.2297del (p.P766Rfs*444)
Variant in GRCh37: RECQL4 (NM_004260.3):c.2296dup (p.V766Gfs*43)
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Identify potential disease-associated variants in GRCh37 and
assess their effect on clinical variant interpretation.

We hypothesized that potential diseaseassociated variants carried by GRCh37
would occur at a high minor allele
frequency (MAF) in CEGS databases. By
filtering the Broad’s gnomAD database and
our internal CEGS variant database for
variants occurring at MAF of 95% or
greater, we systematically identified likely
disease-associated sequences within
GRCh37. We prioritized variants that
resulted in a frameshift, insertion or
deletion (indel), premature stop codon, or
stop codon disruption.

Using population frequency data, we identified 31 variants
within clinically-significant genes in GRCh37. These variants
complicate variant detection in clinical exome and genome
sequencing (CEGS) pipelines.

•

The majority of variants identified are expected to result in a
shift in the reading frame. These not only have implications for
correct variant detection and effect prediction at the variant site
but also all variants occurring downstream.

•

Increased awareness and in-house annotation of diseaseassociated variants harbored by GRCh37 is necessary to
ensure more accurate variant detection.

Results: Variant Example – RecQ-like helicase 4 (RECQL4)
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Future Directions
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Methods: Identification of Sequence Discrepancies
•

•
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Objective
•

•

We identified 31 variants in GRCh37 within 28 genes
associated with clinical phenotypes in OMIM.
Comparison of GRCh37 with GRCh38 revealed that 24 out
of the 31 variants (77.4%) identified in our study were resolved
in the updated genome assembly.

Summary and Discussion
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•

Use the American College of Medical Genetics (ACMG)
scoring criteria to assess the pathogenicity of each variant
identified.

•

Publish a reference list of discrepant variants in GRCh37.

•

Use the reference list of pathogenic discrepant variants in
GRCh37 to develop detection methods for homozygous
variants at these loci.

•

Evaluate our internal CEGS database to determine the
number of carriers of pathogenic or likely-pathogenic
discrepant variants.

•

Assess feasibility of migration to GRCh38 for CEGS analysis
at Children’s Mercy Kansas City.
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Exon 14

Effect on Variant Detection:
•
GRCh37 has an inserted G at chr8:145738768.
•
To resolve this discrepancy, the insertion is masked in the
RefSeq transcript. This generates an additional one base pair
intron and splits exon 14 into two (exon 14 and exon 15).
81%
•
Patients harboring (NM_006331.7):c.2296dup will go
Premature Stop
undetected if using GRCh37.
Sequence variants downstream of c.2296 (NM_004260.3) will
Disruption of Stop •
have incorrect variant effect prediction if aligned to GRCh37.

